| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ziad A Memish | Q76089502 |
| Ali A Rabaan | Q87010484 | ||
| Jaffar A. Al-Tawfiq | Q40672517 | ||
| P2093 | author name string | Awad Al-Omari | |
| Samer Salih | |||
| P2860 | cites work | SARS: systematic review of treatment effects | Q21144696 |
| Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC | Q24329089 | ||
| Middle East respiratory syndrome coronavirus in bats, Saudi Arabia | Q24596439 | ||
| Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines | Q24600523 | ||
| Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group | Q24604486 | ||
| Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control | Q26796501 | ||
| Receptor-binding domain-based subunit vaccines against MERS-CoV | Q26851979 | ||
| The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis | Q27001157 | ||
| Current advancements and potential strategies in the development of MERS-CoV vaccines | Q27012578 | ||
| Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4 | Q27678981 | ||
| Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor | Q27689029 | ||
| Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26 | Q27695604 | ||
| Coronavirus as a possible cause of severe acute respiratory syndrome | Q28200848 | ||
| Characterization of a novel coronavirus associated with severe acute respiratory syndrome | Q28202401 | ||
| Identification of a new human coronavirus | Q29615906 | ||
| Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia | Q29618053 | ||
| The Genome sequence of the SARS-associated coronavirus | Q29619007 | ||
| Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015. | Q30202400 | ||
| Serological assays for emerging coronaviruses: challenges and pitfalls | Q30210679 | ||
| The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic | Q30235533 | ||
| Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis | Q30249264 | ||
| Dromedary Camels and the Transmission of Middle East Respiratory Syndrome Coronavirus (MERS-CoV). | Q30252107 | ||
| Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol | Q30277992 | ||
| Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S | Q56564203 | ||
| Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient | Q64137589 | ||
| Do pulmonary radiographic findings at presentation predict mortality in patients with community-acquired pneumonia? | Q71714527 | ||
| Update: Recommendations for Middle East respiratory syndrome coronavirus (MERS-CoV). | Q42255644 | ||
| First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. | Q42258061 | ||
| MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic | Q42762388 | ||
| Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa | Q42931174 | ||
| Objective Determination of End of MERS Outbreak, South Korea, 2015. | Q43110283 | ||
| Emerging human middle East respiratory syndrome coronavirus causes widespread infection and alveolar damage in human lungs | Q43507223 | ||
| Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. | Q43628487 | ||
| Corticosteroid Therapy for Critically Ill Patients with the Middle East Respiratory Syndrome | Q45073537 | ||
| Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors | Q45659807 | ||
| Middle East respiratory syndrome coronavirus infections in health care workers | Q45723498 | ||
| A new virus isolated from the human respiratory tract | Q45825116 | ||
| Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia. | Q45906708 | ||
| Preventing healthcare-associated transmission of the Middle East Respiratory Syndrome (MERS): Our Achilles heel. | Q46551580 | ||
| Middle East Respiratory Syndrome Coronavirus Nonstructural Protein 16 Is Necessary for Interferon Resistance and Viral Pathogenesis | Q47107616 | ||
| Estimating survival rates in MERS-CoV patients 14 and 45 days after experiencing symptoms and determining the differences in survival rates by demographic data, disease characteristics and regions: a worldwide study. | Q47260596 | ||
| A recombinant VSV-vectored MERS-CoV vaccine induces neutralizing antibody and T cell responses in rhesus monkeys after single dose immunization | Q47288304 | ||
| MERS-CoV 4b protein interferes with the NF-κB-dependent innate immune response during infection. | Q47548908 | ||
| MERS-CoV and H5N1 influenza virus antagonize antigen presentation by altering the epigenetic landscape | Q47552814 | ||
| Development of Middle East Respiratory Syndrome Coronavirus vaccines - advances and challenges | Q47607374 | ||
| Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study. | Q47657940 | ||
| DPP4, the Middle East Respiratory Syndrome Coronavirus Receptor, is Upregulated in Lungs of Smokers and Chronic Obstructive Pulmonary Disease Patients | Q47666922 | ||
| Evaluation of a Real-Time Reverse Transcription-PCR (RT-PCR) Assay for Detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Clinical Samples from an Outbreak in South Korea in 2015. | Q47875863 | ||
| Severe acute respiratory syndrome: radiographic appearances and pattern of progression in 138 patients. | Q51672487 | ||
| Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen. | Q51730564 | ||
| MERS transmission and risk factors: a systematic review. | Q53069767 | ||
| Effect of interferon alpha and cyclosporine treatment separately and in combination on Middle East Respiratory Syndrome Coronavirus (MERS-CoV) replication in a human in-vitro and ex-vivo culture model. | Q54208634 | ||
| Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. | Q54217812 | ||
| Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. | Q54230978 | ||
| Unusual presentation of Middle East respiratory syndrome coronavirus leading to a large outbreak in Riyadh during 2017. | Q54234800 | ||
| MERS-CoV pathogenesis and antiviral efficacy of licensed drugs in human monocyte-derived antigen-presenting cells. | Q54250885 | ||
| Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea. | Q38739674 | ||
| Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus | Q38753926 | ||
| Coronavirus Host Range Expansion and Middle East Respiratory Syndrome Coronavirus Emergence: Biochemical Mechanisms and Evolutionary Perspectives | Q38766689 | ||
| Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome | Q38776321 | ||
| Middle East Respiratory Syndrome Coronavirus: What Does a Radiologist Need to Know? | Q38783084 | ||
| MERS-CoV diagnosis: An update. | Q38815393 | ||
| Patient characteristics infected with Middle East respiratory syndrome coronavirus infection in a tertiary hospital | Q38868439 | ||
| Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus | Q39187107 | ||
| Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. | Q39349816 | ||
| Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection | Q39677274 | ||
| High secretion of interferons by human plasmacytoid dendritic cells upon recognition of Middle East respiratory syndrome coronavirus | Q39794655 | ||
| Human infection with MERS coronavirus after exposure to infected camels, Saudi Arabia, 2013. | Q40009251 | ||
| Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus | Q40041480 | ||
| Inclusion of MERS-spike protein ELISA in algorithm to determine serologic evidence of MERS-CoV infection | Q40041686 | ||
| Structural insights into the Middle East respiratory syndrome coronavirus 4a protein and its dsRNA binding mechanism | Q40044568 | ||
| A Novel Dynamic Model Describing the Spread of the MERS-CoV and the Expression of Dipeptidyl Peptidase 4. | Q40052186 | ||
| Assessing the Detection of Middle East Respiratory Syndrome Coronavirus IgG in Suspected and Proven Cases of Middle East Respiratory Syndrome Coronavirus Infection | Q40057508 | ||
| A review of candidate therapies for Middle East respiratory syndrome from a molecular perspective. | Q40064548 | ||
| Recovery from the Middle East respiratory syndrome is associated with antibody and T-cell responses. | Q40094147 | ||
| Clinical Implications of 5 Cases of Middle East Respiratory Syndrome Coronavirus Infection in a South Korean Outbreak | Q40123706 | ||
| Longitudinal study of Middle East Respiratory Syndrome coronavirus infection in dromedary camel herds in Saudi Arabia, 2014-2015. | Q40152026 | ||
| IFN-α2a or IFN-β1a in combination with ribavirin to treat Middle East respiratory syndrome coronavirus pneumonia: a retrospective study | Q40159258 | ||
| ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice | Q40173497 | ||
| Clinical aspects and outcomes of 70 patients with Middle East respiratory syndrome coronavirus infection: a single-center experience in Saudi Arabia | Q40187493 | ||
| Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia | Q40200316 | ||
| Middle East respiratory syndrome coronavirus disease in children | Q40209279 | ||
| Structural Insights into the Interaction of Coronavirus Papain-Like Proteases and Interferon-Stimulated Gene Product 15 from Different Species. | Q40229759 | ||
| Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets. | Q40252744 | ||
| Differential Expression of the Middle East Respiratory Syndrome Coronavirus Receptor in the Upper Respiratory Tracts of Humans and Dromedary Camels | Q40336588 | ||
| Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ. | Q40359845 | ||
| Middle East Respiratory Syndrome Coronavirus Infection During Pregnancy: A Report of 5 Cases From Saudi Arabia | Q40631027 | ||
| Extensive Positive Selection Drives the Evolution of Nonstructural Proteins in Lineage C Betacoronaviruses | Q36694030 | ||
| Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation. | Q36755302 | ||
| Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection | Q36816625 | ||
| Evolutionary Dynamics of MERS-CoV: Potential Recombination, Positive Selection and Transmission | Q36865015 | ||
| Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients | Q36879745 | ||
| Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV). | Q36884852 | ||
| Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014 | Q36884958 | ||
| The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists | Q36922964 | ||
| MERS-CoV Antibodies in Humans, Africa, 2013-2014. | Q36935271 | ||
| Analytical and Clinical Validation of Six Commercial Middle East Respiratory Syndrome Coronavirus RNA Detection Kits Based on Real-Time Reverse-Transcription PCR. | Q37084139 | ||
| Morphogenesis of Avian Infectious Bronchitis Virus and a Related Human Virus (Strain 229E) | Q37122632 | ||
| Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection | Q37188934 | ||
| Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2. | Q37336487 | ||
| Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay. | Q37358618 | ||
| Middle East respiratory syndrome coronavirus disease is rare in children: An update from Saudi Arabia | Q37399674 | ||
| CD8+ T Cells and Macrophages Regulate Pathogenesis in a Mouse Model of Middle East Respiratory Syndrome | Q37512816 | ||
| Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants | Q37512915 | ||
| Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus | Q37546593 | ||
| X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design | Q37581697 | ||
| Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus | Q37621643 | ||
| A previously undescribed coronavirus associated with respiratory disease in humans | Q37647570 | ||
| Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. | Q37664563 | ||
| Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016 | Q37708530 | ||
| Middle east respiratory syndrome coronavirus 4a protein is a double-stranded RNA-binding protein that suppresses PACT-induced activation of RIG-I and MDA5 in the innate antiviral response. | Q37713995 | ||
| Serologic Evidence for MERS-CoV Infection in Dromedary Camels, Punjab, Pakistan, 2012-2015 | Q37739645 | ||
| Biogenesis and dynamics of the coronavirus replicative structures | Q38064286 | ||
| Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans | Q38229070 | ||
| Human-Dromedary Camel Interactions and the Risk of Acquiring Zoonotic Middle East Respiratory Syndrome Coronavirus Infection. | Q38302221 | ||
| MERS and the dromedary camel trade between Africa and the Middle East | Q38379691 | ||
| Middle East respiratory syndrome coronavirus in children | Q38398169 | ||
| Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond | Q38553361 | ||
| The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling | Q38595331 | ||
| MERS-CoV Accessory ORFs Play Key Role for Infection and Pathogenesis | Q38638572 | ||
| The Evolution of Antiviral Defense Systems | Q38729624 | ||
| Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome | Q36468760 | ||
| Lessons learned from new emerging infectious disease, Middle East Respiratory Syndrome coronavirus outbreak in Korea | Q36488813 | ||
| Treatment strategies for Middle East respiratory syndrome coronavirus | Q36555622 | ||
| Middle East Respiratory Syndrome Coronavirus during Pregnancy, Abu Dhabi, United Arab Emirates, 2013. | Q36617031 | ||
| Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis | Q36625323 | ||
| 3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012 | Q36626864 | ||
| Interhuman transmissibility of Middle East respiratory syndrome coronavirus: estimation of pandemic risk. | Q30351904 | ||
| Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS. | Q30355171 | ||
| Adjunctive therapies and immunomodulating agents for severe influenza. | Q30355446 | ||
| Atlas of coronavirus replicase structure. | Q30357066 | ||
| Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines. | Q30359335 | ||
| Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. | Q30362113 | ||
| Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus. | Q30371303 | ||
| A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform. | Q30378994 | ||
| A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. | Q30379384 | ||
| Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection. | Q30427729 | ||
| Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin | Q30429521 | ||
| Middle East respiratory syndrome coronavirus in Al-Madinah City, Saudi Arabia: Demographic, clinical and survival data | Q31108162 | ||
| Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study | Q33409373 | ||
| Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection | Q33413007 | ||
| Clinical Presentation and Outcomes of Middle East Respiratory Syndrome in the Republic of Korea | Q33434003 | ||
| Hospital outbreak of Middle East respiratory syndrome coronavirus | Q33642332 | ||
| A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein. | Q33743790 | ||
| MERS coronavirus in dromedary camel herd, Saudi Arabia | Q33816384 | ||
| Treatment with interferon-α2b and ribavirin improves outcome in MERS-CoV-infected rhesus macaques | Q33887877 | ||
| Geographic distribution of MERS coronavirus among dromedary camels, Africa | Q33950974 | ||
| Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture | Q34058365 | ||
| Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4. | Q34059153 | ||
| Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat | Q34261861 | ||
| Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction | Q34304123 | ||
| Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. | Q34306978 | ||
| Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. | Q34317027 | ||
| Family cluster of Middle East respiratory syndrome coronavirus infections | Q34347450 | ||
| Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission | Q34347979 | ||
| Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. | Q34376025 | ||
| Interferon-stimulated genes: a complex web of host defenses | Q34405609 | ||
| Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein | Q34408840 | ||
| Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen | Q34442119 | ||
| Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus | Q34455805 | ||
| Protease inhibitors targeting coronavirus and filovirus entry | Q34461982 | ||
| Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice | Q40744757 | ||
| Infection control and prevention practices implemented to reduce transmission risk of Middle East respiratory syndrome-coronavirus in a tertiary care institution in Saudi Arabia. | Q40774751 | ||
| Bioinformatics analysis on molecular mechanism of ribavirin and interferon-α in treating MERS-CoV | Q40776786 | ||
| Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. | Q40777987 | ||
| Notes from the Field: Nosocomial Outbreak of Middle East Respiratory Syndrome in a Large Tertiary Care Hospital--Riyadh, Saudi Arabia, 2015. | Q40786131 | ||
| Acute Middle East Respiratory Syndrome Coronavirus: Temporal Lung Changes Observed on the Chest Radiographs of 55 Patients | Q40808656 | ||
| Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015. | Q40868265 | ||
| Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection | Q40911125 | ||
| Presence of antibodies but no evidence for circulation of MERS-CoV in dromedaries on the Canary Islands, 2015. | Q40923127 | ||
| Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome | Q40940972 | ||
| Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study | Q41088356 | ||
| Middle East Respiratory Syndrome Coronavirus Efficiently Infects Human Primary T Lymphocytes and Activates the Extrinsic and Intrinsic Apoptosis Pathways | Q41094209 | ||
| Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset | Q41096904 | ||
| Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein | Q41199088 | ||
| Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus | Q41242033 | ||
| 2014 MERS-CoV outbreak in Jeddah--a link to health care facilities | Q41351922 | ||
| Middle Eastern Respiratory Syndrome Corona Virus (MERS CoV): case reports from a tertiary care hospital in Saudi Arabia | Q41366475 | ||
| Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study. | Q41718118 | ||
| Characterization of a novel betacoronavirus related to middle East respiratory syndrome coronavirus in European hedgehogs | Q41909110 | ||
| Inhibition of Middle East respiratory syndrome coronavirus infection by anti-CD26 monoclonal antibody | Q41920484 | ||
| Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA. | Q41921387 | ||
| Identification of sialic acid-binding function for the Middle East respiratory syndrome coronavirus spike glycoprotein. | Q41935096 | ||
| Evidence for camel-to-human transmission of MERS coronavirus | Q42212312 | ||
| Respiratory tract samples, viral load, and genome fraction yield in patients with Middle East respiratory syndrome | Q42214884 | ||
| Ribavirin and interferon-α2b as primary and preventive treatment for Middle East respiratory syndrome coronavirus: a preliminary report of two cases | Q42218522 | ||
| Performance and clinical validation of the RealStar MERS-CoV Kit for detection of Middle East respiratory syndrome coronavirus RNA. | Q42224974 | ||
| Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation | Q42236132 | ||
| Screening for Middle East respiratory syndrome coronavirus infection in hospital patients and their healthcare worker and family contacts: a prospective descriptive study | Q42241378 | ||
| Ribavirin and interferon therapy in patients infected with the Middle East respiratory syndrome coronavirus: an observational study | Q42244203 | ||
| Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis | Q42246665 | ||
| Middle East Respiratory Syndrome (MERS) coronavirus seroprevalence in domestic livestock in Saudi Arabia, 2010 to 2013. | Q42248788 | ||
| Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013. | Q42248792 | ||
| Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. | Q42251659 | ||
| Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation | Q42253657 | ||
| Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease | Q34468689 | ||
| MERS coronavirus: diagnostics, epidemiology and transmission | Q34506268 | ||
| Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus | Q34593578 | ||
| MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment | Q34650943 | ||
| Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection | Q34653376 | ||
| Delayed induction of proinflammatory cytokines and suppression of innate antiviral response by the novel Middle East respiratory syndrome coronavirus: implications for pathogenesis and treatment. | Q34656339 | ||
| An observational, laboratory-based study of outbreaks of middle East respiratory syndrome coronavirus in Jeddah and Riyadh, kingdom of Saudi Arabia, 2014. | Q35003400 | ||
| Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation | Q35009468 | ||
| A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines | Q35063993 | ||
| The multifunctional or moonlighting protein CD26/DPPIV. | Q35089114 | ||
| Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein | Q35159147 | ||
| Development and validation of a rapid immunochromatographic assay for detection of Middle East respiratory syndrome coronavirus antigen in dromedary camels | Q35193329 | ||
| Real-time sequence-validated loop-mediated isothermal amplification assays for detection of Middle East respiratory syndrome coronavirus (MERS-CoV). | Q35347932 | ||
| High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014 | Q35860307 | ||
| Development and Evaluation of Novel Real-Time Reverse Transcription-PCR Assays with Locked Nucleic Acid Probes Targeting Leader Sequences of Human-Pathogenic Coronaviruses | Q35868692 | ||
| Multi-Organ Damage in Human Dipeptidyl Peptidase 4 Transgenic Mice Infected with Middle East Respiratory Syndrome-Coronavirus | Q35877765 | ||
| Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus | Q35913859 | ||
| Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27 | Q35964208 | ||
| A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates | Q36069589 | ||
| A sensitive and specific antigen detection assay for Middle East respiratory syndrome coronavirus | Q36073689 | ||
| Middle East Respiratory Coronavirus Accessory Protein 4a Inhibits PKR-Mediated Antiviral Stress Responses | Q36175026 | ||
| Stillbirth during infection with Middle East respiratory syndrome coronavirus | Q36201318 | ||
| Clinical determinants of the severity of Middle East respiratory syndrome (MERS): a systematic review and meta-analysis | Q36207135 | ||
| Molecular Epidemiology of Hospital Outbreak of Middle East Respiratory Syndrome, Riyadh, Saudi Arabia, 2014. | Q36212147 | ||
| Middle East Respiratory Syndrome Coronavirus Superspreading Event Involving 81 Persons, Korea 2015. | Q36241778 | ||
| Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication | Q36269957 | ||
| Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States | Q36293993 | ||
| Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection | Q36306931 | ||
| Middle East respiratory syndrome coronavirus ORF4b protein inhibits type I interferon production through both cytoplasmic and nuclear targets | Q36343316 | ||
| Middle East respiratory syndrome coronavirus infection: virus-host cell interactions and implications on pathogenesis | Q36393296 | ||
| Renal Complications and Their Prognosis in Korean Patients with Middle East Respiratory Syndrome-Coronavirus from the Central MERS-CoV Designated Hospital | Q36400547 | ||
| Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014. | Q36418201 | ||
| Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease | Q36433987 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Coronaviridae | Q1134583 |
| P304 | page(s) | 265-285 | |
| P577 | publication date | 2018-10-18 | |
| 2019-03-01 | |||
| P1433 | published in | Diagnostic Microbiology and Infectious Disease | Q15763479 |
| P1476 | title | MERS coronavirus outbreak: Implications for emerging viral infections | |
| P478 | volume | 93 |
| Q64111229 | Bat Research Networks and Viral Surveillance: Gaps and Opportunities in Western Asia |
| Q64119316 | Bioaerosols and Transmission, a Diverse and Growing Community of Practice |
| Q97528635 | Drug targets for COVID-19 therapeutics: Ongoing global efforts |
| Q108832741 | Effect of ORF7 of SARS-CoV-2 on the Chemotaxis of Monocytes and Neutrophils In Vitro |
| Q97521731 | Flattening the COVID-19 Curve With Natural Killer Cell Based Immunotherapies |
| Q102141614 | High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents |
| Q84316149 | Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? |
| Q97527042 | Importance of the One Health approach to study the SARS-CoV-2 in Latin America |
| Q91579137 | Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development |
| Q64359214 | New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility |
| Q92102886 | Recent apprise on coronavirus and its terrible insinuations |
| Q97537589 | Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice |
| Q102378266 | Structure of nonstructural protein 1 from SARS-CoV-2 |
| Q98613568 | Susceptibility to SARS, MERS, and COVID-19 from animal health perspective |
| Q98288123 | The 2019-2020 Novel Coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) Pandemic: A Joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus P |
| Q89840059 | The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? |
| Q92117598 | The epidemiological and clinical features of COVID-19 and lessons from this global infectious public health event |
| Q91935487 | The epidemiology and clinical information about COVID-19 |
| Q98461071 | Where we missed? Middle East Respiratory Syndrome (MERS-CoV) epidemiology in Saudi Arabia; 2012-2019 |
| Q107982009 | Why All the Fury over Furin? |
Search more.